nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrofolic acid—Methotrexate—bone cancer	0.447	1	CrCtD
Tetrahydrofolic acid—ATIC—Methotrexate—bone cancer	0.1	0.537	CbGbCtD
Tetrahydrofolic acid—Pralatrexate—Methotrexate—bone cancer	0.0591	0.2	CrCrCtD
Tetrahydrofolic acid—Raltitrexed—Methotrexate—bone cancer	0.0591	0.2	CrCrCtD
Tetrahydrofolic acid—Pemetrexed—Methotrexate—bone cancer	0.0591	0.2	CrCrCtD
Tetrahydrofolic acid—Leucovorin—Methotrexate—bone cancer	0.0591	0.2	CrCrCtD
Tetrahydrofolic acid—Folic Acid—Methotrexate—bone cancer	0.0591	0.2	CrCrCtD
Tetrahydrofolic acid—MTHFR—Methotrexate—bone cancer	0.0416	0.223	CbGbCtD
Tetrahydrofolic acid—ABCC2—Carboplatin—bone cancer	0.0151	0.0806	CbGbCtD
Tetrahydrofolic acid—ABCC2—Cisplatin—bone cancer	0.0129	0.0689	CbGbCtD
Tetrahydrofolic acid—ABCC2—Doxorubicin—bone cancer	0.00862	0.0462	CbGbCtD
Tetrahydrofolic acid—ABCC2—Methotrexate—bone cancer	0.00835	0.0447	CbGbCtD
Tetrahydrofolic acid—ATIC—pes—bone cancer	0.00381	0.189	CbGeAlD
Tetrahydrofolic acid—MTHFD1—Metabolism of folate and pterines—DHFR—bone cancer	0.00277	0.0588	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Folate Metabolism—FOLR1—bone cancer	0.00257	0.0544	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Folate Metabolism—FOLR1—bone cancer	0.00205	0.0435	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Folate Metabolism—FOLR1—bone cancer	0.00194	0.0412	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—leg—bone cancer	0.00194	0.0961	CbGeAlD
Tetrahydrofolic acid—ATIC—forelimb—bone cancer	0.00193	0.0954	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Nucleotide Metabolism—DHFR—bone cancer	0.00191	0.0404	CbGpPWpGaD
Tetrahydrofolic acid—AMT—One Carbon Metabolism—DHFR—bone cancer	0.00185	0.0391	CbGpPWpGaD
Tetrahydrofolic acid—ALDH1L1—One Carbon Metabolism—DHFR—bone cancer	0.00185	0.0391	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—hindlimb—bone cancer	0.00173	0.0858	CbGeAlD
Tetrahydrofolic acid—AMT—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.00166	0.0352	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism of folate and pterines—DHFR—bone cancer	0.00155	0.0328	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—appendage—bone cancer	0.00149	0.0736	CbGeAlD
Tetrahydrofolic acid—MTHFD2—One Carbon Metabolism—DHFR—bone cancer	0.0014	0.0296	CbGpPWpGaD
Tetrahydrofolic acid—MTFMT—One Carbon Metabolism—DHFR—bone cancer	0.0014	0.0296	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—One Carbon Metabolism—DHFR—bone cancer	0.0014	0.0296	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.00126	0.0266	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Folate Metabolism—FOLR1—bone cancer	0.00115	0.0243	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—One Carbon Metabolism—DHFR—bone cancer	0.00112	0.0237	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—One Carbon Metabolism—DHFR—bone cancer	0.00106	0.0225	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.001	0.0213	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism of folate and pterines—DHFR—bone cancer	0.000961	0.0204	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.000953	0.0202	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Nucleotide metabolism—NT5C3A—bone cancer	0.000894	0.0189	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Folate Metabolism—FOLR1—bone cancer	0.000869	0.0184	CbGpPWpGaD
Tetrahydrofolic acid—Methotrexate—FOLR1—bone cancer	0.000845	0.325	CrCbGaD
Tetrahydrofolic acid—ATIC—One Carbon Metabolism—DHFR—bone cancer	0.000824	0.0175	CbGpPWpGaD
Tetrahydrofolic acid—Pralatrexate—DHFR—bone cancer	0.000784	0.301	CrCbGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—FOLR1—bone cancer	0.000711	0.0151	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Folate Metabolism—DHFR—bone cancer	0.000704	0.0149	CbGpPWpGaD
Tetrahydrofolic acid—MTFMT—connective tissue—bone cancer	0.000694	0.0343	CbGeAlD
Tetrahydrofolic acid—Pemetrexed—DHFR—bone cancer	0.000627	0.241	CrCbGaD
Tetrahydrofolic acid—SHMT1—One Carbon Metabolism—DHFR—bone cancer	0.000625	0.0132	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—connective tissue—bone cancer	0.000586	0.029	CbGeAlD
Tetrahydrofolic acid—MTHFD1—Folate Metabolism—DHFR—bone cancer	0.000563	0.0119	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.000561	0.0119	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Folate Metabolism—DHFR—bone cancer	0.000534	0.0113	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—BMI1—bone cancer	0.000521	0.0111	CbGpPWpGaD
Tetrahydrofolic acid—ALDH1L1—tendon—bone cancer	0.000517	0.0256	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Doxorubicin—Epirubicin—bone cancer	0.000511	0.519	CbGdCrCtD
Tetrahydrofolic acid—ALDH1L1—spinal cord—bone cancer	0.000498	0.0246	CbGeAlD
Tetrahydrofolic acid—MTFMT—tendon—bone cancer	0.000477	0.0236	CbGeAlD
Tetrahydrofolic acid—MTR—One Carbon Metabolism—DHFR—bone cancer	0.000473	0.01	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Epirubicin—Doxorubicin—bone cancer	0.000473	0.481	CbGdCrCtD
Tetrahydrofolic acid—MTFMT—bone marrow—bone cancer	0.000462	0.0228	CbGeAlD
Tetrahydrofolic acid—MTFMT—spinal cord—bone cancer	0.00046	0.0227	CbGeAlD
Tetrahydrofolic acid—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000455	0.00965	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000451	0.00957	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000426	0.00904	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.000426	0.00902	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—connective tissue—bone cancer	0.000425	0.021	CbGeAlD
Tetrahydrofolic acid—AMT—tendon—bone cancer	0.000421	0.0208	CbGeAlD
Tetrahydrofolic acid—AMT—bone marrow—bone cancer	0.000408	0.0202	CbGeAlD
Tetrahydrofolic acid—AMT—spinal cord—bone cancer	0.000406	0.0201	CbGeAlD
Tetrahydrofolic acid—MTHFD1—tendon—bone cancer	0.000403	0.0199	CbGeAlD
Tetrahydrofolic acid—MTHFD1—bone marrow—bone cancer	0.00039	0.0193	CbGeAlD
Tetrahydrofolic acid—MTHFD1—spinal cord—bone cancer	0.000389	0.0192	CbGeAlD
Tetrahydrofolic acid—MTHFR—One Carbon Metabolism—DHFR—bone cancer	0.000388	0.00821	CbGpPWpGaD
Tetrahydrofolic acid—MTR—connective tissue—bone cancer	0.000359	0.0178	CbGeAlD
Tetrahydrofolic acid—MTHFR—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.000348	0.00738	CbGpPWpGaD
Tetrahydrofolic acid—Methotrexate—DHFR—bone cancer	0.000346	0.133	CrCbGaD
Tetrahydrofolic acid—SHMT2—tendon—bone cancer	0.000341	0.0168	CbGeAlD
Tetrahydrofolic acid—MTHFR—Fluoropyrimidine Activity—DHFR—bone cancer	0.00034	0.0072	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—bone marrow—bone cancer	0.00033	0.0163	CbGeAlD
Tetrahydrofolic acid—SHMT1—Folate Metabolism—DHFR—bone cancer	0.000315	0.00667	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—tendon—bone cancer	0.00031	0.0153	CbGeAlD
Tetrahydrofolic acid—SHMT1—bone marrow—bone cancer	0.0003	0.0149	CbGeAlD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—EIF2S1—bone cancer	0.000292	0.00619	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.000291	0.00617	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—spinal cord—bone cancer	0.000281	0.0139	CbGeAlD
Tetrahydrofolic acid—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000252	0.00535	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000249	0.00528	CbGpPWpGaD
Tetrahydrofolic acid—MTR—tendon—bone cancer	0.000247	0.0122	CbGeAlD
Tetrahydrofolic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000245	0.00519	CbGpPWpGaD
Tetrahydrofolic acid—MTR—bone marrow—bone cancer	0.000239	0.0118	CbGeAlD
Tetrahydrofolic acid—MTR—Folate Metabolism—DHFR—bone cancer	0.000238	0.00505	CbGpPWpGaD
Tetrahydrofolic acid—MTR—spinal cord—bone cancer	0.000238	0.0118	CbGeAlD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—DHFR—bone cancer	0.000195	0.00414	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000191	0.00405	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.00017	0.00359	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—NDUFA12—bone cancer	0.000166	0.00352	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Folate Metabolism—TP53—bone cancer	0.000157	0.00334	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000156	0.00332	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00015	0.00318	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—CDK4—bone cancer	0.000143	0.00303	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000143	0.00303	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—NT5C3A—bone cancer	0.000138	0.00292	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Phase II conjugation—GSTP1—bone cancer	0.000137	0.00291	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—NDUFA12—bone cancer	0.000133	0.00282	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—tendon—bone cancer	0.00013	0.00642	CbGeAlD
Tetrahydrofolic acid—MTHFD1—Folate Metabolism—TP53—bone cancer	0.000126	0.00267	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Folate Metabolism—TP53—bone cancer	0.000119	0.00253	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—NT5C3A—bone cancer	0.00011	0.00233	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—NDUFA12—bone cancer	9.8e-05	0.00208	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	9.47e-05	0.00201	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Biological oxidations—CYP3A4—bone cancer	9.39e-05	0.00199	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—MMP9—bone cancer	8.97e-05	0.0019	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—NT5C3A—bone cancer	8.12e-05	0.00172	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Biological oxidations—GSTP1—bone cancer	8.03e-05	0.0017	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Fluoropyrimidine Activity—TP53—bone cancer	7.59e-05	0.00161	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—NDUFA12—bone cancer	7.43e-05	0.00157	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	7.18e-05	0.00152	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Selenium Micronutrient Network—PTGS2—bone cancer	7.11e-05	0.00151	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Folate Metabolism—TP53—bone cancer	7.03e-05	0.00149	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—NT5C3A—bone cancer	6.15e-05	0.0013	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—bone cancer	6.09e-05	0.00129	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—ENO2—bone cancer	6.03e-05	0.00128	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	5.87e-05	0.00124	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Selenium Micronutrient Network—PTGS2—bone cancer	5.82e-05	0.00123	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—ENO2—bone cancer	5.76e-05	0.00122	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—NDUFA12—bone cancer	5.63e-05	0.00119	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—DHFR—bone cancer	5.6e-05	0.00119	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—DHFR—bone cancer	5.34e-05	0.00113	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Folate Metabolism—TP53—bone cancer	5.33e-05	0.00113	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—GNA11—bone cancer	5.23e-05	0.00111	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—ENO2—bone cancer	4.82e-05	0.00102	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—CYP3A4—bone cancer	4.74e-05	0.00101	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—NT5C3A—bone cancer	4.66e-05	0.000988	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—NDUFA12—bone cancer	4.61e-05	0.000976	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—DHFR—bone cancer	4.48e-05	0.000949	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—TP53—bone cancer	4.36e-05	0.000924	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—GNA11—bone cancer	4.18e-05	0.000886	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—GSTP1—bone cancer	4.06e-05	0.00086	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—TGFBR2—bone cancer	3.87e-05	0.000821	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—NT5C3A—bone cancer	3.82e-05	0.000809	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—NRF2 pathway—GSTP1—bone cancer	3.81e-05	0.000808	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—NRF2 pathway—TGFBR2—bone cancer	3.81e-05	0.000808	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—CYP3A4—bone cancer	3.79e-05	0.000804	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—ENO2—bone cancer	3.56e-05	0.000754	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—DHFR—bone cancer	3.3e-05	0.000699	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—GSTP1—bone cancer	3.24e-05	0.000687	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—ENO2—bone cancer	3.22e-05	0.000682	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—GNA11—bone cancer	3.08e-05	0.000654	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3e-05	0.000635	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—DHFR—bone cancer	2.99e-05	0.000633	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—CYP3A4—bone cancer	2.8e-05	0.000593	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—ENO2—bone cancer	2.7e-05	0.000571	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—KIT—bone cancer	2.64e-05	0.00056	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.59e-05	0.000548	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—DHFR—bone cancer	2.5e-05	0.00053	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—BRAF—bone cancer	2.48e-05	0.000526	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—ENO2—bone cancer	2.44e-05	0.000517	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—GSTP1—bone cancer	2.39e-05	0.000507	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GNA11—bone cancer	2.34e-05	0.000495	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—DHFR—bone cancer	2.26e-05	0.00048	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—TGFBR2—bone cancer	2.16e-05	0.000459	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—CYP3A4—bone cancer	2.12e-05	0.000449	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—PTGS2—bone cancer	2.1e-05	0.000445	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—MDM2—bone cancer	2.08e-05	0.000441	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—ENO2—bone cancer	2.04e-05	0.000433	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—PTGS2—bone cancer	2.01e-05	0.000425	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—ENO2—bone cancer	2e-05	0.000423	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—DHFR—bone cancer	1.9e-05	0.000402	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—DHFR—bone cancer	1.85e-05	0.000393	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GSTP1—bone cancer	1.81e-05	0.000384	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GNA11—bone cancer	1.77e-05	0.000375	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—PTGS2—bone cancer	1.68e-05	0.000356	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—ENO2—bone cancer	1.67e-05	0.000354	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—TGFBR2—bone cancer	1.64e-05	0.000348	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—CYP3A4—bone cancer	1.61e-05	0.00034	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—DHFR—bone cancer	1.55e-05	0.000329	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—KIT—bone cancer	1.48e-05	0.000313	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GNA11—bone cancer	1.45e-05	0.000307	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—EGFR—bone cancer	1.42e-05	0.000301	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—BRAF—bone cancer	1.39e-05	0.000294	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GSTP1—bone cancer	1.37e-05	0.000291	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—TGFBR2—bone cancer	1.34e-05	0.000284	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—CYP3A4—bone cancer	1.31e-05	0.000279	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—PTGS2—bone cancer	1.24e-05	0.000263	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—MDM2—bone cancer	1.16e-05	0.000246	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GSTP1—bone cancer	1.12e-05	0.000238	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—PTGS2—bone cancer	1.12e-05	0.000238	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—KIT—bone cancer	1.12e-05	0.000237	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—BRAF—bone cancer	1.05e-05	0.000223	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—PTGS2—bone cancer	9.39e-06	0.000199	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—KIT—bone cancer	9.16e-06	0.000194	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—MDM2—bone cancer	8.81e-06	0.000187	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—BRAF—bone cancer	8.61e-06	0.000182	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—PTGS2—bone cancer	8.5e-06	0.00018	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—EGFR—bone cancer	7.95e-06	0.000168	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—MDM2—bone cancer	7.21e-06	0.000153	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—PTGS2—bone cancer	7.12e-06	0.000151	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—PTGS2—bone cancer	6.95e-06	0.000147	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—EGFR—bone cancer	6.02e-06	0.000128	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—PTGS2—bone cancer	5.82e-06	0.000123	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—EGFR—bone cancer	4.93e-06	0.000104	CbGpPWpGaD
